AUREOZOL GRANULAR 500 AUREOZOL 500G- chlortetracycline calcium, sulfathiazole and penicillin g procaine granule 
Alpharma, LLC.

----------

AureoZol®
Granular 500

Aureomycin® chlortetracycline,
sulfathiazole and penicillin
Type A Medicated Article

Active drug ingredients

Chlortetracycline calcium complex equivalent to

Chlortetracycline HCl ............................................................................... 40 g / lb
Sulfathiazole .................................................................................. 8.8% (40 g / lb)
Penicillin (from procaine penicillin) .......................................................... 20 g / lb

Ingredients

Dried Streptomyces aureofaciens Fermentation Product and calcium sulfate.

For use in the manufacture of medicated swine feeds. For animal use only.

Use directions

Provide 100 g/ton chlortetracycline, 100 g/ton sulfathiazole, and 50 g/ton of penicillin by thoroughly mixing 2.5 lb (1.14 kg) of AureoZol 500 Granular into each ton (907.2 kg) of complete swine feed for the following indications.

Type of swine feed – permitted claims and limitations

For Use in Swine Feeds as Specified Below:

Pre-starter and Starter Feeds

Administer to swine in a complete medicated feed for reduction of the incidence of cervical abscesses; treatment of bacterial enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); maintenance of weight gains in the presence of atrophic rhinitis; increased rate of weight gain and improved feed efficiency from 10 pounds of body weight to 6 weeks postweaning. For swine raised in confinement (dry-lot) or on limited pasture.

Grower and Finisher Feeds

Administer to swine in a complete medicated feed for reduction of the incidence of cervical abscesses; treatment of bacterial enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); maintenance of weight gains in the presence of atrophic rhinitis; increased rate of weight gain from 6 to 16 weeks post-weaning. For swine raised in confinement (dry-lot) or on limited pasture.

Caution

In order to achieve the desired performance results, feed as the sole ration.

Warning

Withdraw 7 days prior to slaughter.

Note: Manufacture of Type B or C feeds from this product requires a Medicated Feed License Application approved by FDA.

ANADA #200-167, Approved by FDA

Restricted Drug (California) - Use only as directed.
Not for human use.

Marketed by
Alpharma Inc.
Bridgewater, New Jersey 08807

Net wt 50 LB (22.68 kg)

Take Time Observe Label Directions

Made in USA

Trademarks
registered by
Alpharma Inc.

700339 0909

PRINCIPAL DISPLAY PANEL - 50 LB Label

AureoZol®
Granular 500

ALPHARMA

Aureomycin® chlortetracycline,
sulfathiazole and penicillin
Type A Medicated Article

See mixing directions, claims, cautions
and warnings on back

Net wt 50 LB (22.68 kg)

ALPHARMA®

AureoZol®
Granular 500

Principal Display Panel - 50 LB Label
AUREOZOL GRANULAR 500  AUREOZOL 500G
chlortetracycline calcium, sulfathiazole and penicillin g procaine granule
Product Information
Product TypeOTC TYPE A MEDICATED ARTICLE ANIMAL DRUGItem Code (Source)NDC:46573-022
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Sulfathiazole (UNII: Y7FKS2XWQH) (Sulfathiazole - UNII:Y7FKS2XWQH) Sulfathiazole40 g  in 0.45 kg
Penicillin G (UNII: Q42T66VG0C) (Penicillin G - UNII:Q42T66VG0C) Penicillin G20 g  in 0.45 kg
Procaine (UNII: 4Z8Y51M438) (Procaine - UNII:4Z8Y51M438) Procaine20 g  in 0.45 kg
Inactive Ingredients
Ingredient NameStrength
Calcium Sulfate (UNII: WAT0DDB505)  
Product Characteristics
Colorbrown (light brown) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:46573-022-0022.68 kg in 1 BAG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANADAANADA20016701/01/200912/31/2014
Labeler - Alpharma, LLC. (070954094)

Revised: 6/2022
 
Alpharma, LLC.